Overview
This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.
Eligibility
Inclusion Criteria:
- Premenopausal
- In spontaneous menstrual cycle (no hormonal treatments for the last 3 months)
- Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy
Exclusion Criteria:
- HIV or Hepatitis positive
- Pregnancy